Hosted on MSN7h
Harris Has 'Narrow' Path to Win Election, Evercore's Bianchi Says
Sarah Bianchi, Evercore ISI chief strategist of political affairs and public policy, says some of the exit-poll data are ...
Focus on Trump trade proxies — bitcoin and Chinese yuan — as election results come in: Evercore's Emanuel
Proxies for former President Donald Trump's trade policies — specifically bitcoin and the Chinese yuan — can help gauge what market participants are making of the election results, Julian Emanuel, ...
Uber’s real threat isn’t from robots
The ride-hailing pioneer is contending with slowing bookings growth, rising insurance costs and an alliance between DoorDash ...
FiercePharma18h
Analysts point to Syfovre 'nadir' after Apellis discloses disappointing quarter
Despite witnessing modest growth in demand over the past three months, Apellis Pharmaceuticals’ complement inhibitor for ...
Evercore ISI Keeps Their Hold Rating on 8X8 (EGHT)
In a report released today, Peter Levine from Evercore ISI maintained a Hold rating on 8X8 (EGHT – Research Report), with a price target ...
Evercore ISI Reaffirms Their Buy Rating on Progressive (PGR)
Evercore ISI analyst David Motemaden maintained a Buy rating on Progressive (PGR – Research Report) today and set a price target of ...
FiercePharma23h
Madrigal’s Rezdiffra has launched a new MASH market, but ‘tremendous change’ is on the horizon
With the FDA approval of the first specific drug for Metabolic Associated Steatohepatitis (MASH) in March this year, Madrigal’s Rezdiffra is a pioneer in a market set for rapid change. | With the FDA ...